Bristol-Myers Squibb Co (CHIX:BRMD) Accounts Payable : €3,126 Mil (As of Sep. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Bristol-Myers Squibb Co Accounts Payable?

Bristol-Myers Squibb Co's Accounts Payable for the quarter that ended in Sep. 2024 was €3,126 Mil.

Bristol-Myers Squibb Co's quarterly Accounts Payable increased from Mar. 2024 (€3,256 Mil) to Jun. 2024 (€3,485 Mil) but then declined from Jun. 2024 (€3,485 Mil) to Sep. 2024 (€3,126 Mil).

Bristol-Myers Squibb Co's annual Accounts Payable increased from Dec. 2021 (€2,610 Mil) to Dec. 2022 (€2,870 Mil) and increased from Dec. 2022 (€2,870 Mil) to Dec. 2023 (€2,989 Mil).

Bristol-Myers Squibb Co Accounts Payable Historical Data

The historical data trend for Bristol-Myers Squibb Co's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bristol-Myers Squibb Co Accounts Payable Chart

Bristol-Myers Squibb Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable

Get a 7-Day Free Trial

2,200.50

2,230.09

2,609.87

2,869.76

2,988.50

Bristol-Myers Squibb Co Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Accounts Payable	Get a 7-Day Free Trial															2,635.78	2,988.50	3,255.88	3,484.68	3,125.57

Bristol-Myers Squibb Co Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Bristol-Myers Squibb Co Accounts Payable Related Terms

Thank you for viewing the detailed overview of Bristol-Myers Squibb Co's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Bristol-Myers Squibb Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bristol-Myers Squibb Co (CHIX:BRMd) » Definitions » Accounts Payable

Comparable Companies

Traded in Other Exchanges

BMYMP.PFD:USA BMY:USA BMY:Peru BMY:Mexico 1BMY:Italy 0R1F:UK BRM:Germany BRM:Germany BRM:Germany BRM:Germany BMYB34:Brazil BMYS:Austria BMY:Argentina

Address

Route 206 and Province Line Road, Princeton, New Jersey, NJ, USA, 08543

Website

https://www.bms.com

Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.

Bristol-Myers Squibb Co Headlines

No Headlines